IVOGVanguard S&P Mid-Cap 400 Growth Index Fund ETF Shares
Seeks to track the performance of a benchmark index that measures the investment return of mid-capitalization growth stocks in the United States.
By Vanguard · Launched 2010
Annual Cost
0.10%
#539 of 5,562 · low cost
Fund Size
$1.8B
#785 of 5,562 · large
Return (1Y)Goal
+32.6%
Track Record
15 years
#811 of 5,562 · established
Performance
Total-return NAV · USDGrowth of $10,000
$12,810+28.1%
Total-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundAsset class
EquityRegion
North americaCap
Mid
Strategy
Index tracking
Factor
Growth
Index tracked
S&P MidCap 400 Growth Index
What it actually holds
By weightConcentration
Top 10 holdings = 13.3% of fund✓ well diversified
Comfort Systems USA Inc
2.0%
Pure Storage Inc
1.6%
Coherent Corp
1.5%
United Therapeutics Corp
1.3%
Curtiss-Wright Corp
1.3%
Twilio Inc
1.2%
TechnipFMC PLC
1.1%
RB Global Inc
1.1%
Guidewire Software Inc
1.1%
Woodward Inc
1.1%
Asset allocation
Stocks
99.3%
Cash
0.5%
Other
0.3%
By sector
Industrials
30.0%
Technology
24.8%
Healthcare
13.7%
Consumer Cyclical
7.5%
Financial Services
6.8%
Real Estate
5.3%
Basic Materials
3.5%
Energy
3.2%
Other
5.2%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
17.6%Moderate
Year-on-year price swings
Max drawdown
-39.3%Severe
Worst peak-to-trough loss
Sharpe (3Y)
0.75Decent risk-adjusted returns
Sortino (3Y)
1.11Good downside protection
Where to buy
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks to track the performance of a benchmark index that measures the investment return of mid-capitalization growth stocks in the United States.
- Strategy
- Invests primarily in stocks of mid-cap growth companies in the U.S. by tracking the S&P MidCap 400 Growth Index. Aims to replicate the index by holding stocks in approximately the same proportion as their index weightings.
- Inception date
- September 7, 2010
- Fund family
- Vanguard
Similar ETFs
Closest matches by profileWhat's next?
You've reviewed IVOG. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19